Cannabis in Singapore

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Cannabis in Singapore is currently illegal for recreational purposes, but medicinal purposes has been allowed under extraordinary circumstances in recent years. Possession or consumption can result in a maximum of 10 years in prison, with a possible fine of $20,000, as well as caning,[1] under the Misuse of Drugs Act. Trafficking, import or export of more than 500 grams may result in the death penalty.[2][3]

History[edit]

Cannabis was likely introduced to Singapore by immigrant laborers from South Asia, who often used cannabis in their homelands. This origin is witnessed by the use of the now archaic Indian term ganja to label cannabis in Singapore, even among non-Indians.[4] Cannabis was banned in Singapore in 1870, during the British colonial period under the Straits Settlements.[5]

Government view[edit]

The government has argued that its strict laws on drugs, which includes cannabis, is due to Singapore's proximity to the Golden Triangle, a popular transit point and market for drug trafficking.[6]

In 2016, a Straits Times article reported that there were 252 new drug cases by the National Addictions Management Service in the previous year involving people aged below 30, compared with 136 in 2014, further citing that such "cases of young people influenced by growing acceptance of drug overseas [is] a worrying trend". Singaporean politician Christopher de Souza, who chairs the Government Parliamentary Committee for Home Affairs and Law later stated that "to decriminalize the recreational consumption of cannabis is a foolish proposal. It entrenches a higher tolerance for drugs in community."[7]

Medical cannabis[edit]

While the legalisation of recreational cannabis is unlikely to happen in Singapore under the ruling People's Action Party (PAP) government in the near future, in recent years the usage of medicinal cannabis has been relaxed but nevertheless remains severely restricted, and it's often been considered as the drug of last resort after all treatment options has been exhausted.

The Singapore's National Research Foundation (NRF) announced on January 10, 2018 that it would develop synthetic medicinal cannabinoids, or chemical compounds found in the marijuana plant, to eventually help treat diseases such as Alzheimer's and Parkinson's. Part of a broader S$25 million ($19 million) investment by the body into synthetic biology, the initiative is intended to boost Singapore's push to develop a “bio-based economy,” and grow new industries and create jobs in a sustainable way.[8]

As of 2021, two people with treatment-resistant epilepsy have been granted permission to use medicinal cannabis. The permission is for a cannabinoid pharmaceutical also known as Epidiolex.[9]

References[edit]

  1. ^ "Drugs and Inhalants". Central Narcotics Bureau. Central Narcotics Bureau, Ministry of Home Affairs, Singapore. 6 August 2013. Archived from the original on 7 September 2015. Retrieved 3 October 2013.
  2. ^ "MISUSE OF DRUGS ACT". Attorney-General's Chamber. Singapore Government. 31 March 2008. Retrieved 3 October 2013.
  3. ^ "Central Narcotics Bureau Singapore". Archived from the original on 2017-08-08. Retrieved 2017-08-07.
  4. ^ Stanley Einstein (1980). The Community's response to drug use. Pergamon Press. p. 71. ISBN 978-0-08-019597-1.
  5. ^ Nanthawan Bunyapraphatsō̜n (1999). Medicinal and poisonous plants. Backhuys Publishers. p. 169. ISBN 978-90-5782-042-7.
  6. ^ Lee, Desmond. "S'pore's choice: Drug-free, not drug-tolerant". todayonline.com. Retrieved 20 August 2021.
  7. ^ "More Singapore youth seeking help for cannabis abuse". 2016-02-21.
  8. ^ "A country that punishes drug traffickers with death is investing in medical marijuana".
  9. ^ "Cannabis-derived drug approved for second patient". 17 June 2021.